Whether your public company trades OTC or on the NYSE, investor relations will be part of your annual expenditures. Every industry wants to sell products that make their members the most money. The Spinoff saves you money. But, securities attorneys lose income. U. S. brokerage firms make less money doing Private Placement than public offerings.
Financial printers lose money, etc.
It isn't in the Industries best interest to mention a Spinoff to the CFO of a private company. Most OTC company insiders want to dump their stock quickly. Since insiders can get free trading stock by buying a Trading Shell, they avoid Spinoffs. Few public companies will sponsor Spinoffs because of the legal liability problem. Spinoffs work, but they may not work for your company.